Global Cardiac Ablation Market 2017-2021

心臓アブレーション治療の世界市場

◆タイトル:Global Cardiac Ablation Market 2017-2021
◆商品コード:IRTNTR12660
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年4月26日
◆ページ数:70
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、心臓アブレーション治療の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、心臓アブレーション治療の世界市場規模及び予測、製品別分析、需要先別分析、地域別分析/市場規模、購買基準、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

ABSTRACTAbout Cardiac Ablation

Cardiac ablation is an endovascular procedure that helps to treat an irregular heart rhythm and is performed with the help of an ablation device and catheter. These products use radio frequency (RF) as an energy source to destroy unhealthy heart tissues. Ablation catheters remove faulty electrical pathways from the heart, thereby reducing the risk of ventricular fibrillation and sudden cardiac arrest. Cardiac arrhythmias are characterized by an abnormal heart rhythm, which is lower than 60 beats per minute, more than 100 beats per minute, or irregular. The improper functioning of the electrical systems regulating the heart can cause arrhythmia. Arrhythmias are of various types, including atrial fibrillation, atrial flutter, and atrioventricular nodal re-entrant tachycardia.

Technavio’s analysts forecast the global cardiac ablation market to grow at a CAGR of 7.6% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global cardiac ablation market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Cardiac Ablation Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Boston Scientific
• Medtronic
• St. Jude Medical

[Other prominent vendors]
• AblaCor
• Advanced Cardiac Therapeutics
• AngioDynamics
• APT Medical
• AtriCure
• BIOTRONIK
• Biosense Webster
• CardioFocus
• DVx
• Galgo Medical
• Hansen Medical
• Imricor
• Lepu Medical
• Melys AFS
• MicroPor Scientific
• Osypka Medical
• PLC Medical Systems
• Spectranetics
• VytronUS

[Market driver]
• Rising incidences of cardiac diseases and growth of insurance providers.
• For a full, detailed list, view our report

[Market challenge]
• Complications associated with cardiac ablation and stringent regulatory framework.
• For a full, detailed list, view our report

[Market trend]
• Transforming marketing and sales strategies for cardiac ablation.
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Key market highlights

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by product
• Global cardiac ablation devices market
• Cardiac ablation catheters market

PART 07: Market segmentation by procedures
• Atrial fibrillation ablation
• Supraventricular tachycardia ablation
• Ventricular tachycardia ablation

PART 08: Market segmentation by end-user
• Hospitals and clinics
• ASCs

PART 09: Geographical segmentation
• Cardiac ablation market in Americas
• Cardiac ablation market in EMEA
• Cardiac ablation market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges
• Market drivers
• Impact of drivers on key customer segments
• Market challenges
• Impact of challenges on key customer segments

PART 12: Market trends
• Transforming marketing and sales strategies for cardiac ablation
• Emergence of digital cath labs in hospitals
• Integration of robotic cardiac catheter system and hybrid operating room equipment

PART 13: Vendor landscape
• Competitive landscape

PART 14: Key vendor analysis
• Boston Scientific
• Medtronic
• St. Jude Medical
• Other prominent vendors

PART 15: Appendix
• List of abbreviations

[List of Exhibits]

Exhibit 01: Global cardiac ablation market overview 2016
Exhibit 02: Global cardiac ablation market 2016-2021 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Global cardiac ablation market by product 2016 and 2021 ($ billions)
Exhibit 05: Buying criteria of cardiac ablation products 2016 and 2021
Exhibit 06: Market overview: Global cardiac ablation devices market
Exhibit 07: Global cardiac ablation devices market 2016-2021 ($ billions)
Exhibit 08: Market overview: Cardiac ablation catheters market
Exhibit 09: Global cardiac ablation catheters market 2016-2021 ($ billions)
Exhibit 10: Global cardiac ablation market by procedures in 2016
Exhibit 11: Global cardiac ablation market by end-user in 2016
Exhibit 12: Global cardiac ablation market by geography 2016 and 2021 ($ billions)
Exhibit 13: An overview of cardiac diseases in US
Exhibit 14: Market overview: Cardiac ablation market in Americas
Exhibit 15: Cardiac ablation market in Americas 2016-2021 ($ billions)
Exhibit 16: Cardiac ablation market in Americas: Market analysis by country
Exhibit 17: Market overview: Cardiac ablation market in US
Exhibit 18: Impact of accountable care organizations (ACO) and ACA on cardiac ablation
Exhibit 19: Market overview: Cardiac ablation market in Europe
Exhibit 20: Cardiac ablation market in EMEA 2016-2021 ($ billions)
Exhibit 21: Cardiac ablation market in EMEA: Market analysis by country
Exhibit 22: Market overview: Cardiac ablation market in UK
Exhibit 23: Market overview: Cardiac ablation market in APAC
Exhibit 24: Cardiac ablation market in APAC 2016-2021 ($ billions)
Exhibit 25: Cardiac ablation market in APAC: Market analysis by country
Exhibit 26: Market overview: Cardiac ablation market in South Korea
Exhibit 27: Increasing number of CVDs (hypertension) versus number of Medicare providers in US 2011-2013
Exhibit 28: Clinical studies for cardiac ablation: Companies and CROs
Exhibit 29: Impact of drivers
Exhibit 30: Cost of cardiac ablation products
Exhibit 31: Research studies: Complications associated with cardiac ablation
Exhibit 32: Product recalls 2014-2015
Exhibit 33: Impact of challenges
Exhibit 34: Marketing and sales strategies by large and small companies
Exhibit 35: Competitive structure analysis of global cardiac ablation market 2016
Exhibit 36: Competitive landscape of global cardiac ablation market 2016
Exhibit 37: Global cardiac ablation market: Market penetration of companies 2016
Exhibit 38: Strategies of large and small companies in global cardiac ablation market
Exhibit 39: Boston Scientific: Strength assessment
Exhibit 40: Boston Scientific: Strategy assessment
Exhibit 41: Boston Scientific: Opportunity assessment
Exhibit 42: Medtronic: Strength assessment
Exhibit 43: Medtronic: Strategy assessment
Exhibit 44: Medtronic: Opportunity assessment
Exhibit 45: St. Jude Medical: Strength assessment
Exhibit 46: St. Jude Medical: Strategy assessment
Exhibit 47: St. Jude Medical: Opportunity assessment
Exhibit 48: Other prominent vendors in global cardiac ablation market



【掲載企業】

Boston Scientific, Medtronic, St. Jude Medical, AblaCor, Advanced Cardiac Therapeutics, and AngioDynamics.

【資料のキーワード】

心臓アブレーション、アブレーション治療、心臓アブレーション装置、カテーテルアブレーション、カテーテル

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[心臓アブレーション治療の世界市場] (Global Cardiac Ablation Market 2017-2021 / IRTNTR12660)販売に関する免責事項
[心臓アブレーション治療の世界市場] (Global Cardiac Ablation Market 2017-2021 / IRTNTR12660)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆